Skip to main content
Log in

Virushepatitis

HCV-Präventionsstrategien bei i. v.-Drogengebrauch

  • journal club
  • Published:
Gastro-News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. WHO. Global health sector strategy on viral hepatitis 2016-21

  2. WHO. Combating Hepatitis B and C to reach elimination by 2030

  3. CDA Foundation. Working globally to eliminate Hepatitis by 2030

  4. EASL 2018, https://doi.org/10.1016/j.jhep.2018.03.026

    Article  Google Scholar 

  5. www.bundesregierung.de/Content/Infomaterial/BMG/_2851.html

  6. www.deutsche-leberstiftung.de/aktuelles/archiv/aktionsplan/aktionsplan_virushepatitis_final_web.pdf

  7. RKI. Epidemiologisches Bulletin. 26. Juli 2018 / Nr. 30 285–98

  8. RKI. Epidemiologisches Bulletin. 26. Juli 2018 / Nr. 30 285–98

Literatur

  • Delile JM, de Ledinghen V, Jauffret-Roustide M, Roux P, Reiller B, Foucher J, Dhumeaux D. Hepatitis C virus prevention and care for drug injectors: the french approach. Hepatology, Medicine and Policy 2018;3:7

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Claus Niederau.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Niederau, C. HCV-Präventionsstrategien bei i. v.-Drogengebrauch. Gastro-News 5, 29–30 (2018). https://doi.org/10.1007/s15036-018-0502-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15036-018-0502-3

Navigation